We have located links that may give you full text access.
Journal Article
Review
Current Status and Future Directions of Nanoparticulate Strategy for Cancer Immunotherapy.
BACKGROUND: Rapid advancement over the past few decades in cancer immunotherapy provides life-saving options for cancer patients. However, commonly used strategies including small molecules and various biomacromolecule-based therapeutics suffer from serious off-target toxicity and a lack of stability in the circulation.
OBJECTIVE: To overcome these problems, various nanoparticulate delivery systems have been developed to achieve controlled and sustained drug release, improved stability and pharmacokinetic profiles, and tumor specificity to reduce off-target adverse effects.
METHOD: We reviewed representative studies on multiple nanoparticulate platform systems for delivering therapeutics in cancer immunotherapy, and discussed the advances and perspectives for the future development of novel therapeutics in cancer immunotherapy. Results and Perspectives: Nanoparticles for the controlled delivery of immune modulating agents represents a viable approach in cancer immunotherapy. Besides seeking novel carrier systems or new materials, efforts need to be contributed to delineating the impact of intrinsic properties of nanoparticles such as material composition, morphology, size distribution, charge, and stiffness in manipulating immune responses in cancer therapy.
OBJECTIVE: To overcome these problems, various nanoparticulate delivery systems have been developed to achieve controlled and sustained drug release, improved stability and pharmacokinetic profiles, and tumor specificity to reduce off-target adverse effects.
METHOD: We reviewed representative studies on multiple nanoparticulate platform systems for delivering therapeutics in cancer immunotherapy, and discussed the advances and perspectives for the future development of novel therapeutics in cancer immunotherapy. Results and Perspectives: Nanoparticles for the controlled delivery of immune modulating agents represents a viable approach in cancer immunotherapy. Besides seeking novel carrier systems or new materials, efforts need to be contributed to delineating the impact of intrinsic properties of nanoparticles such as material composition, morphology, size distribution, charge, and stiffness in manipulating immune responses in cancer therapy.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app